Biotechnology / Partnerships

Delaware science institute nabs big-name collabo with Cali’s Zymergen

The bicoastal project with STRIDE will develop new technology for coatings, adhesives and films.

Life Sciences in Delaware (Photo by Flickr user Amy, used under a Creative Commons license)

The Science Technology and Research Institute of Delaware (STRIDE) has entered a research and development agreement with the California molecular technology company Zymergen.

Zymergen has gotten some big press recently for its diversity — Vanity Fair reported in April that a third of its software engineers are women in a time when Facebook, Google and Uber haven’t cracked 20 percent — and for its innovative use of machine learning (the science behind AI) in biotechnology. The project with STRIDE will focus on developing new technology for applications such as films, coatings and adhesives.

“We are excited to be working with Zymergen in our labs here in Delaware,” said Dr. Seetha Coleman-Kammula, CEO of STRIDE. “When Zymergen approached us, we quickly put together an excellent team of experts in films, coatings, adhesives and analytical chemistry and gathered the necessary laboratory infrastructure to help them get to market faster and more efficiently. This is at the heart of our value proposition.”

Founded in 2016, STRIDE is a consultancy and R&D organization with labs at the Delaware Innovation Space in Wilmington and the University of Delaware campus in Newark.


Knowledge is power!

Subscribe for free today and stay up to date with news and tips you need to grow your career and connect with our vibrant tech community.


What roles do gender and race play in the IT job market?

Looking for a resilient career? Check out these 13 local orgs

This Week in Jobs: Sketch out a new role with these 28 tech career opportunities

How I Got Here: Det Ansinn's career as a CTO and founder taught him to prioritize the people behind the tech

Technically Media